Innocan Pharma (INNPF) Depreciation & Amortization (CF) (2024 - 2025)
Innocan Pharma's Depreciation & Amortization (CF) was $12,000 in the quarter ended Dec 31, 2025, up 100.0% from $6,000 a year earlier and up 9.1% from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Depreciation & Amortization (CF) at Innocan Pharma came in at $42,000, up 20.0% from the prior year.
- In earlier years, Depreciation & Amortization (CF) was $35,000 in the year ended Dec 31, 2024 (+6.1%) and $33,000 in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Depreciation & Amortization (CF) in data going back to the quarter ended Mar 31, 2024.
- Compared with a year earlier, Depreciation & Amortization (CF) was higher in two of the last four quarters, with growth averaging 28.1%.
- Per Business Quant data, INNPF's Depreciation & Amortization (CF) in the three quarters before the quarter ended Dec 31, 2025 was $11,000 (quarter ended Sep 30, 2025), $9,000 (quarter ended Jun 30, 2025) and $10,000 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 12,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
API Access
Innocan Pharma Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();